Ads
related to: sanofi- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- News
Stay current on all things Vertex
and discover the latest news.
- Contact Us
Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 2 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 3 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 2 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via AOL· 4 days agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 3 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
Delaware Judge Lets More Than 70,000 Zantac Lawsuits Go Forward
US News & World Report· 1 day agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a setback for former Zantac makers GSK, Pfizer, Sanofi and Boehringer Ingelheim ...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 6 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 3 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has been extended, but ...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoNow in its 10th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to secure that employees benefit from the company growth and success ...